Infect Chemother.  2017 Sep;49(3):213-218. 10.3947/ic.2017.49.3.213.

Causes of HIV Drug Non-Adherence in Korea: Korea HIV/AIDS Cohort Study, 2006-2015

Affiliations
  • 1Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea. ksw2kms@knu.ac.kr
  • 2Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
  • 3Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • 4Division of Infectious Diseases, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • 5Division of AIDS, Korea Centers for Disease Control and Prevention, Cheongju, Korea.
  • 6Institute for Health and Society, Hanyang University, Seoul, Korea.
  • 7Department of Preventive Medicine, Hanyang University College of Medicine, Seoul, Korea.
  • 8Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • 9AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
  • 10Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
  • 11Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.

Abstract

We aimed to determine the initial adherence of HIV cohort patients to ART (antiretroviral therapy), and reasons for non-adherence. Patients who received ART at the time of enrollment in the Korea HIV/AIDS Cohort were included in this study. Treatment adherence was determined at the baseline interview by self-reported questionnaire. Eight-hundred thirty two HIV-infected patients received ART. Of these, 253 (30.4%) patients skipped ART more than once a month. The most common reason of skipping medication was "simply forgot" (60.4%).

Keyword

Human immunodeficiency virus; Cohort Study; Adherence

MeSH Terms

Cohort Studies*
HIV*
Humans
Korea*

Reference

1. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000; 133:21–30.
Article
2. Ickovics JR, Cameron A, Zackin R, Bassett R, Chesney M, Johnson VA, Kuritzkes DR. Adult AIDS Clinical Trials Group 370 Protocol Team. Consequences and determinants of adherence to antiretroviral medication: results from Adult AIDS Clinical Trials Group protocol 370. Antivir Ther. 2002; 7:185–193.
Article
3. Korean Society for AIDS. The 2015 clinical guidelines for the treatment and prevention of opportunistic infections in HIV-infected Koreans: guidelines for opportunistic infections. Infect Chemother. 2016; 48:54–60.
4. Walsh JC, Pozniak AL, Nelson MR, Mandalia S, Gazzard BG. Virologic rebound on HAART in the context of low treatment adherence is associated with a low prevalence of antiretroviral drug resistance. J Acquir Immune Defic Syndr. 2002; 30:278–287.
Article
5. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, Wu AW. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000; 12:255–266.
Article
6. Park Y, Seo MJ, Kim S, Park SY. Experience of treatment adherence in Korean patients with HIV. J Korean Acad Nurs. 2014; 44:407–417.
Article
7. Choi JY, Park YS, Kim CO, Park YS, Yoon HJ, Shin SY, Kim YA, Song YG, Kim JM. Correlation between adherence to antiretroviral treatment and virologic failure in HIV-infected Koreans. Infect Chemother. 2005; 37:9–15.
8. Kim MJ, Kim SW, Chang HH, Kim Y, Jin S, Jung H, Park JH, Kim S, Lee JM. Comparison of antiretroviral regimens: adverse effects and tolerability failure that cause regimen switching. Infect Chemother. 2015; 47:231–238.
Article
9. Fong OW, Ho CF, Fung LY, Lee FK, Tse WH, Yuen CY, Sin KP, Wong KH. Determinants of adherence to highly active antiretroviral therapy (HAART) in Chinese HIV/AIDS patients. HIV Med. 2003; 4:133–138.
Article
10. Ortego C, Huedo-Medina TB, Llorca J, Sevilla L, Santos P, Rodríguez E, Warren MR, Vejo J. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011; 15:1381–1396.
Article
11. Reynolds NR, Testa MA, Marc LG, Chesney MA, Neidig JL, Smith SR, Vella S, Robbins GK. Protocol Teams of ACTG 384, ACTG 731 and A5031s. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study. AIDS Behav. 2004; 8:141–150.
Article
12. Barfod TS, Sørensen HT, Nielsen H, Rodkjaer L, Obel N. ‘Simply forgot’ is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence. HIV Med. 2006; 7:285–290.
Article
13. Maggiolo F, Ripamonti D, Arici C, Gregis G, Quinzan G, Camacho GA, Ravasio L, Suter F. Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patients. HIV Clin Trials. 2002; 3:371–378.
Article
14. Stout BD, Leon MP, Niccolai LM. Nonadherence to antiretroviral therapy in HIV-positive patients in Costa Rica. AIDS Patient Care STDS. 2004; 18:297–304.
Article
15. Molassiotis A, Nahas-Lopez V, Chung WY, Lam SW, Li CK, Lau TF. Factors associated with adherence to antiretroviral medication in HIV-infected patients. Int J STD AIDS. 2002; 13:301–310.
Article
16. Cambiano V, Lampe FC, Rodger AJ, Smith CJ, Geretti AM, Lodwick RK, Puradiredja DI, Johnson M, Swaden L, Phillips AN. Long-term trends in adherence to antiretroviral therapy from start of HAART. AIDS. 2010; 24:1153–1162.
Article
Full Text Links
  • IC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr